The immune reboot proposes to reorganize and balance the immune system in autoimmunity through specialized therapies that seek real cures.
This new oncological technology could achieve significant advances for cancer to stop hiding and be detectable by the patient's immune system, without the classic side effects. This is how this new device works.
In a significant breakthrough in breast cancer research, the Weizmann Institute of Science in Israel has developed an antibody capable of blocking the molecular connections that tumors use to evade the immune response.